OA10142A - Dérivés de lipopeptide procédé pour leur préparation médicaments les contenant et leur utilisation - Google Patents

Dérivés de lipopeptide procédé pour leur préparation médicaments les contenant et leur utilisation Download PDF

Info

Publication number
OA10142A
OA10142A OA60632A OA60632A OA10142A OA 10142 A OA10142 A OA 10142A OA 60632 A OA60632 A OA 60632A OA 60632 A OA60632 A OA 60632A OA 10142 A OA10142 A OA 10142A
Authority
OA
OAPI
Prior art keywords
formula
lipopeptide
aliphatic acyl
nco
acyl radical
Prior art date
Application number
OA60632A
Other languages
English (en)
French (fr)
Inventor
Rudolf Dr Latrell
Theodor Dr Wollmann
Holger Dr Wallmeier
Peter Dr Hammann
Dieter Dr Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA10142A publication Critical patent/OA10142A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
OA60632A 1994-03-30 1995-03-30 Dérivés de lipopeptide procédé pour leur préparation médicaments les contenant et leur utilisation OA10142A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
OA10142A true OA10142A (fr) 1996-12-18

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60632A OA10142A (fr) 1994-03-30 1995-03-30 Dérivés de lipopeptide procédé pour leur préparation médicaments les contenant et leur utilisation

Country Status (25)

Country Link
US (1) US5629288A (hu)
EP (1) EP0688789B1 (hu)
JP (1) JP3653119B2 (hu)
KR (1) KR100360129B1 (hu)
CN (1) CN1111640A (hu)
AT (1) ATE219499T1 (hu)
AU (1) AU696566B2 (hu)
CA (1) CA2145826C (hu)
CZ (1) CZ287158B6 (hu)
DE (2) DE4411025A1 (hu)
DK (1) DK0688789T3 (hu)
ES (1) ES2178657T3 (hu)
FI (1) FI951468A (hu)
HK (1) HK1012017A1 (hu)
HU (1) HU218286B (hu)
IL (1) IL113160A (hu)
MA (1) MA23490A1 (hu)
NO (1) NO951198L (hu)
NZ (1) NZ270828A (hu)
OA (1) OA10142A (hu)
PL (1) PL180274B1 (hu)
PT (1) PT688789E (hu)
RU (1) RU2141970C1 (hu)
TW (1) TW336939B (hu)
ZA (1) ZA952555B (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU9464398A (en) * 1997-10-21 1999-05-10 Sankyo Company Limited Novel antifungal compounds
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
WO2000063239A1 (fr) * 1999-04-16 2000-10-26 Sankyo Company, Limited Nouveaux composes antifongiques
US7408025B2 (en) * 1999-12-15 2008-08-05 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
US6911525B2 (en) 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
AU784942B2 (en) * 1999-12-15 2006-08-03 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
AU2001278933B2 (en) * 2000-07-17 2006-05-25 Migenix Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
NZ571597A (en) 2000-12-18 2010-05-28 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified daptomycin lipopeptides
RU2348647C2 (ru) 2001-08-06 2009-03-10 Кьюбист Фармасьютикалз, Инк Новые депсипептиды и способы их получения
JP4402463B2 (ja) * 2002-01-03 2010-01-20 マイジェニックス インコーポレイテッド リポペプチド抗生物質のＤａｂ９誘導体およびそれを製造および使用する方法
CA2530063A1 (en) 2003-06-26 2005-01-06 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7994791B2 (en) * 2007-02-19 2011-08-09 Schlumberger Technology Corporation Resistivity receiver spacing
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
RS53152B (en) * 2008-12-22 2014-06-30 Cubist Pharmaceuticals Inc. NEW ANTIBACTERIAL AGENTS FOR TREATMENT OF Gram POSITIVE INFECTIONS
HUE039967T2 (hu) 2009-11-23 2019-02-28 Cubist Pharmaceuticals Llc Lipopeptid kompozíció és ezzel kapcsolatos eljárások
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
PL307914A1 (en) 1995-10-02
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
CN1111640A (zh) 1995-11-15
PL180274B1 (pl) 2001-01-31
RU95106362A (ru) 1996-12-27
PT688789E (pt) 2002-11-29
DE4411025A1 (de) 1995-10-05
IL113160A0 (en) 1995-06-29
KR100360129B1 (ko) 2003-03-26
CA2145826A1 (en) 1995-10-01
ES2178657T3 (es) 2003-01-01
KR950032636A (ko) 1995-12-22
AU696566B2 (en) 1998-09-10
DE59510246D1 (de) 2002-07-25
RU2141970C1 (ru) 1999-11-27
TW336939B (en) 1998-07-21
CZ77995A3 (en) 1995-10-18
NZ270828A (en) 1996-10-28
ATE219499T1 (de) 2002-07-15
US5629288A (en) 1997-05-13
HK1012017A1 (en) 1999-07-23
NO951198L (no) 1995-10-02
JPH07278186A (ja) 1995-10-24
HU218286B (en) 2000-07-28
FI951468A0 (fi) 1995-03-28
EP0688789A1 (de) 1995-12-27
FI951468A (fi) 1995-10-01
CZ287158B6 (en) 2000-10-11
MA23490A1 (fr) 1995-10-01
DK0688789T3 (da) 2002-10-14
AU1611095A (en) 1995-10-12
ZA952555B (en) 1995-12-21
NO951198D0 (no) 1995-03-29
CA2145826C (en) 2008-01-08
JP3653119B2 (ja) 2005-05-25
HUT71584A (en) 1995-12-28

Similar Documents

Publication Publication Date Title
OA10142A (fr) Dérivés de lipopeptide procédé pour leur préparation médicaments les contenant et leur utilisation
EP0773956B1 (fr) Forme purifiee de streptogramines, sa preparation et les compositions pharmaceutiques qui la contiennent
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
EP0274453A2 (fr) Nouveaux composés à activité d'inhibiteurs de collagénase, procédé pour les préparer et compositions pharmaceutiques contenant ces composés
FR2561651A1 (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments
CH638196A5 (fr) Analogues de la prostaglandine i(2) et compositions pharmaceutiques les contenant.
EP0178980B1 (fr) Dérivés de céphalosporines, procédé d'obtention et leur application à titre d'antibiotiques
EP0316218A1 (fr) Nouveaux dérivés de l-proline, leur préparation et leurs applications biologiques
EP0282374B1 (fr) Nouveaux dérivés peptidiques à structure polycyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2698628A1 (fr) Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
CA1251000A (fr) Dipeptides, leur preparation et les medicaments qui les contiennent
EP1189932B1 (fr) Derives de l'echinocandine, leur procede de preparation et leur application comme antifongiques
CN1373770A (zh) 假单胞菌素前药
CH637930A5 (fr) Analogues de la prostaglandine i(2) et compositions pharmaceutiques les contenant.
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
BE886575A (fr) Derives de noyaux peptidiques cycliques, leur preparation et leur utilisation comme agents antifongiques
EP1189933B1 (fr) Derives de l'echinocandine, leur procede de preparation et leur application comme antifongiques
BE856403A (fr) Derives d'imidazole-4-carboxamide 5-0-acyles, procede pour leur preparation et medicaments en contenant
EP0269512B1 (fr) Dérivés des céphalosporines à pharmacocinétique améliorée, procédé pour leur préparation et compositions pharmaceutiques les contenant
BE844377R (fr) Peptides
EP0828740B1 (fr) Derives du 2-azabicyclo[2.2.1]heptane, leur preparation et leur application
LU82182A1 (fr) Analogues de la prostaglandine i2 et les compositions pharmaceutiques les contenant
JP4452078B2 (ja) ヒドロペリレン誘導体
FR2621589A1 (fr) Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2737891A1 (fr) Analogues chiraux de la 15-deoxyspergualine, procede de preparation et utilisation en therapeutique